L2- The concept of agonism Flashcards
explain how conventional agonists change cellular activity
Agonist binding induces a favourable conformational change in the binding site that is transmitted through to other regions of the receptor (activation)
The activated receptor binds to & stimulates downstream signalling pathways, to induce a change in cellular activity
define the term efficacy
the a measure of an agonists ability to activate a receptor, once bound
what is the relationship between full and patrial agonists and antagonists
Full agonist: high efficacy
- high receptor response
- large cellular effect
Partial agonist: lower efficacy
- less receptor response
Antagonists bind to receptors but cannot activate them so they have, no efficacy
define the agonist-induced effect
The agonist-induced effect is the capacity of a bound agonist to produce an activity change within the cell
what is f
efficiency of coupling
- this measures the strength of downstream signalling pathways
what is RT
Receptor density
- this measures the number of receptors at the cell surface
define the relationship between the agonist-induced effect and f, [A], efficacy, KA and RT
The greater these factors the stronger the agonist-induced effect
define the term agonist potency
describes the relationship between dose & effect
how is agonist potency measured
EC50 which is the dose at which the drug produces 50% of its maximum response
what is the relationship between potency and EC50
Inverse
- the lower the EC50 the higher the potency
describe the concept of biased agonism
Different agonists can activate the same receptor to cause the activation of differing signalling pathways (preferential)
What are the potential benefits of biased agonism
Biased agonism will enable the separation of therapeutic and
adverse effects of a single molecule acting through a single receptor
Give a drug example of the benefits of biased agonism
TRV130 (Oliceridine)
- This is an analgesic drug that preferentially activates G-protein pathways to manage pain
- Traditional analgesics such as morphine activate G-protein and Beta-arrestin pathways leading to unwanted adverse effects like respiratory depression
System and receptor bias
Receptor bias – modification of a
receptor (e.g. through mutations, differential splicing, PTMs), which alters its interaction with ligands and/or effectors.
System bias – differential expression of effector elements biases specific signalling outputs over others. e.g. f